Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer

Philip E. Castle, Mark Schiffman, David R. Scott, Mark E. Sherman, Andrew G. Glass, Brenda B. Rush, John E. Schussler, Sholom Wacholder, Attila T. Lorincz

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

We examined whether higher human papillomavirus type 16 (HPV16) viral load predicted risk of cervical intraepithelial neoplasia 3 (CIN3) or cancer (together termed ≥CIN3) within a cohort of 20,810 women followed for 10 years with cytologic screening. Semiquantitative viral load for HPV16 was measured on baseline cervicovaginal specimens using a type-specific hybridization probe test with signal amplification. An increased risk of ≥CIN3 associated with higher HPV16 viral load was found only among cytologically negative women in early follow-up, suggesting that these cases were related to the detection of prevalent lesions missed at baseline. Women with higher HPV16 viral load were more likely to undergo ablative treatment during follow-up than those with lower viral load (Ptrend = 0.008), possibly diminishing any additional risk for ≥CIN3 attributable to higher HPV16 viral loads.

Original languageEnglish (US)
Pages (from-to)1311-1314
Number of pages4
JournalCancer Epidemiology Biomarkers and Prevention
Volume14
Issue number5
DOIs
StatePublished - May 2005

Fingerprint

Human papillomavirus 16
Viral Load
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
Neoplasms

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer. / Castle, Philip E.; Schiffman, Mark; Scott, David R.; Sherman, Mark E.; Glass, Andrew G.; Rush, Brenda B.; Schussler, John E.; Wacholder, Sholom; Lorincz, Attila T.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 14, No. 5, 05.2005, p. 1311-1314.

Research output: Contribution to journalArticle

Castle, Philip E. ; Schiffman, Mark ; Scott, David R. ; Sherman, Mark E. ; Glass, Andrew G. ; Rush, Brenda B. ; Schussler, John E. ; Wacholder, Sholom ; Lorincz, Attila T. / Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer. In: Cancer Epidemiology Biomarkers and Prevention. 2005 ; Vol. 14, No. 5. pp. 1311-1314.
@article{1edbc31b5ca741b790b7d2ef3340bc75,
title = "Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer",
abstract = "We examined whether higher human papillomavirus type 16 (HPV16) viral load predicted risk of cervical intraepithelial neoplasia 3 (CIN3) or cancer (together termed ≥CIN3) within a cohort of 20,810 women followed for 10 years with cytologic screening. Semiquantitative viral load for HPV16 was measured on baseline cervicovaginal specimens using a type-specific hybridization probe test with signal amplification. An increased risk of ≥CIN3 associated with higher HPV16 viral load was found only among cytologically negative women in early follow-up, suggesting that these cases were related to the detection of prevalent lesions missed at baseline. Women with higher HPV16 viral load were more likely to undergo ablative treatment during follow-up than those with lower viral load (Ptrend = 0.008), possibly diminishing any additional risk for ≥CIN3 attributable to higher HPV16 viral loads.",
author = "Castle, {Philip E.} and Mark Schiffman and Scott, {David R.} and Sherman, {Mark E.} and Glass, {Andrew G.} and Rush, {Brenda B.} and Schussler, {John E.} and Sholom Wacholder and Lorincz, {Attila T.}",
year = "2005",
month = "5",
doi = "10.1158/1055-9965.EPI-04-0799",
language = "English (US)",
volume = "14",
pages = "1311--1314",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer

AU - Castle, Philip E.

AU - Schiffman, Mark

AU - Scott, David R.

AU - Sherman, Mark E.

AU - Glass, Andrew G.

AU - Rush, Brenda B.

AU - Schussler, John E.

AU - Wacholder, Sholom

AU - Lorincz, Attila T.

PY - 2005/5

Y1 - 2005/5

N2 - We examined whether higher human papillomavirus type 16 (HPV16) viral load predicted risk of cervical intraepithelial neoplasia 3 (CIN3) or cancer (together termed ≥CIN3) within a cohort of 20,810 women followed for 10 years with cytologic screening. Semiquantitative viral load for HPV16 was measured on baseline cervicovaginal specimens using a type-specific hybridization probe test with signal amplification. An increased risk of ≥CIN3 associated with higher HPV16 viral load was found only among cytologically negative women in early follow-up, suggesting that these cases were related to the detection of prevalent lesions missed at baseline. Women with higher HPV16 viral load were more likely to undergo ablative treatment during follow-up than those with lower viral load (Ptrend = 0.008), possibly diminishing any additional risk for ≥CIN3 attributable to higher HPV16 viral loads.

AB - We examined whether higher human papillomavirus type 16 (HPV16) viral load predicted risk of cervical intraepithelial neoplasia 3 (CIN3) or cancer (together termed ≥CIN3) within a cohort of 20,810 women followed for 10 years with cytologic screening. Semiquantitative viral load for HPV16 was measured on baseline cervicovaginal specimens using a type-specific hybridization probe test with signal amplification. An increased risk of ≥CIN3 associated with higher HPV16 viral load was found only among cytologically negative women in early follow-up, suggesting that these cases were related to the detection of prevalent lesions missed at baseline. Women with higher HPV16 viral load were more likely to undergo ablative treatment during follow-up than those with lower viral load (Ptrend = 0.008), possibly diminishing any additional risk for ≥CIN3 attributable to higher HPV16 viral loads.

UR - http://www.scopus.com/inward/record.url?scp=18544381256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18544381256&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-04-0799

DO - 10.1158/1055-9965.EPI-04-0799

M3 - Article

C2 - 15894692

AN - SCOPUS:18544381256

VL - 14

SP - 1311

EP - 1314

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 5

ER -